| 摘要 |
The present invention relates to the use of dihydropteridinones of formula 1 wherein the groups X, R<SUP>1</SUP>, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP>, R<SUP>5</SUP>, R<SUP>6 </SUP>and R<SUP>7 </SUP>have the meanings given in the claims and specification, for the preparation of a medicament for the treatment of respiratory diseases.
|
